🔎 Trials Near Me

ホーム › 神経芽腫 › ジョージア州

ジョージア州における神経芽腫の臨床試験

ジョージア州内の拠点で、神経芽腫に関する9件の研究が参加者を募集しています。

ジョージア州内の都市

公式研究テキスト(英語)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
被験者募集中第3相
30歳以下 · 全性別 · 2026/10/02更新 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Augusta University Health, Augusta
被験者募集中第2相
22歳以下 · 全性別 · 2026/09/04更新 · NCT02559778

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
被験者募集中第3相
365 Days – 30 Years · 全性別 · 2026/08/25更新 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Augusta University Health, Augusta
被験者募集中第2相
12 Months – 21 Years · 全性別 · 2026/08/12更新 · NCT05489887

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/05/19更新 · NCT04901702

Neuroblastoma Biology Study

  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta
被験者募集中観察研究
31 Days – 99 Years · 全性別 · 2026/03/23更新 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

  • Children's Healthcare of Atlanta, Atlanta
被験者募集中
17歳以下 · 全性別 · 2026/02/10更新 · NCT06831552

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

  • Children's Healthcare of Atlanta, Atlanta
被験者募集中第1相
12 Months · 全性別 · 2025/12/26更新 · NCT05400603

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。